Thousands of obese people in England are expected to be prescribed Wegovy, also known as semaglutide, after health authorities approve its use. The medication works by making people feel full, indicating they eat less
Overview
A “game breaker” weight loss medication used among public figures, including Twitter CEO Elon Musk, will be granted access through the NHS, prompting fears that the drug is not a “miracle cure.”
Thousands of obese people in England are set to be recommended Wegovy, also known as semaglutide, in a “historic moment” after health officials approved its use.
Billionaire Musk stated that he uses Wegovy to stay in shape. Steadily for the past October, Musk was questioned by a Twitter user on the platform what his secret was to looking “appropriate, pulled, and healthy,” to which he replied, “fasting” and “Wegovy.”
Final Note
Patients on the NHS will use a pen to inject themselves weekly, and the drug makes people feel full, causing them to eat less and lose weight.
It resembles the hormone glucagon-like peptide-1 (GLP-1), which is set to release after eating. A previous study found that people who took the medication lost 12% of their body weight after 68 weeks.
